Eversana Life Science Services, Llc Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Eversana Life Science Services, Llc Pharmaceutical Import Records from India — 18 Products, $28.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Eversana Life Science Services, Llc — Pharmaceutical Importer Profile (2026) | 18 Products, $28.0M Trade | TransData Nexus

Eversana Life Science Services, Llc

Pharmaceutical Importer · United States · Cardiovascular Focus · $28.0M Total Trade · DGFT Verified

Eversana Life Science Services, Llc is a pharmaceutical importer based in United States with a total trade value of $28.0M across 18 products in 10 therapeutic categories. Based on 723 verified import shipments from Indian Customs (DGFT) records, Eversana Life Science Services, Llc is the #1 buyer in 2 products including Amoxicillin, Glimepiride. Eversana Life Science Services, Llc sources from 2 verified Indian suppliers, with Rubicon Research Private Limited accounting for 75.9% of imports.

Eversana Life Science Services, Llc — Import Portfolio & Supplier Network

Eversana Life Science Services, Llc import network — 18 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Eversana Life Science Services, Llc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Rubicon Research Private Limited	$13.6M	533	75.9%
Rubicon Research Limited	$4.3M	134	24.1%

Eversana Life Science Services, Llc sources from 2 verified Indian suppliers across .

What Formulations Does Eversana Life Science Services, Llc Import?

Formulation	Value	Ships
'metoprolol tart. TAB USP 25MG,1000's	$620.6K	24
Cyclobenzaprine hcl TAB USP 10mg1000	$381.4K	9
Carbidopa and levodopa tablets USP	$350.0K	7
Metoprolol tart.TAB USP 100MG,1000's	$214.0K	14
40702 tramadol hcl TAB USP 50MG 1000 72888-080-00 batch no.as per	$212.2K	9
Cyclobenzaprine hcl tablets USP 10MG	$200.0K	4
Metoprolol tartrate tablets USP 25MG	$200.0K	4
Triamterene & hctz TAB USP 75/50 MG 500	$200.0K	4
Potassium chloride er tablets USP	$200.0K	4
Tramadol hcl TAB USP 100MG 100's batchno.as per	$200.0K	4
Metoprolol tart. TAB USP 25MG,1000's	$177.6K	5
Cyclobenzaprine hydrochloride tablets	$168.0K	5
Metoprolol tar TAB USP 75MG 100 tru	$150.0K	3
41131 baclofen TAB USP 15MG 100 tru 52817-318-10 3120	$150.0K	3
41131 baclofen TAB USP 15MG 100 tru 52817-318-10 3144	$150.0K	3

Eversana Life Science Services, Llc imports 349 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 18 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Metoprolol	Cardiovascular	$6.0M	193	0.7%	11
2	Clindamycin	Antibiotics	$4.2M	84	3.2%	2
3	Amoxicillin	Antibiotics	$3.8M	75	0.3%	1
4	Glimepiride	Diabetes & Endocrine	$2.2M	76	1.7%	1
5	Heparin	Cardiovascular	$1.9M	38	0.5%	11
6	Potassium	Nutritional Supplements	$1.9M	38	0.3%	14
7	Ketorolac	Analgesics & Antipyretics	$1.6M	32	0.9%	10
8	Carvedilol	Cardiovascular	$1.3M	35	1.3%	12
9	Syringe	Medical Devices & Diagnostics	$1.2M	24	0.7%	9
10	Enoxaparin	Cardiovascular	$1.1M	22	0.5%	7
11	Celecoxib	Analgesics & Antipyretics	$1.0M	52	0.8%	18
12	Clonazepam	CNS & Psychiatric	$575.4K	17	0.3%	9
13	Levothyroxine	Diabetes & Endocrine	$350.0K	7	0.5%	8
14	Isosorbide	Cardiovascular	$317.6K	7	0.7%	13
15	Bortezomib	Advanced Oncology	$300.0K	6	1.4%	9
16	Nitroglycerin	Cardiovascular	$122.3K	13	1.3%	14
17	Diphenhydramine	Antihistamines & Allergy	$100.0K	2	0.3%	18
18	Vati	Ayurvedic & Herbal Products	$100.0K	2	0.4%	17

Eversana Life Science Services, Llc imports 18 pharmaceutical products across 10 categories into United States totaling $28.0M. The company is the #1 buyer for 2 products: Amoxicillin, Glimepiride.

Eversana Life Science Services, Llc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Eversana Life Science Services, LLC is a leading independent provider of global services to the life sciences industry, specializing in the commercialization of pharmaceutical and healthcare products. Established in 1995, the company is headquartered in Milwaukee, Wisconsin, and operates across the United States. Eversana offers a comprehensive suite of integrated solutions that span all stages of the product lifecycle, including market access, product launch support, patient services, and distribution. Their client base comprises over 650 organizations, ranging from innovative start-ups to established pharmaceutical companies, all aiming to advance life sciences solutions for a healthier world.

In August 2024, Eversana Life Science Services, LLC was recognized for its extensive supply chain network, encompassing 37 subsidiaries and 42 tier 1 supply chain connections. The company has also secured government contracts, with a total revenue of $828,000 over the past three years. (data.ark.ai) This underscores Eversana's significant role in the pharmaceutical distribution landscape, highlighting its capacity to manage complex supply chains and deliver integrated services to a diverse clientele.

2Distribution Network

Eversana Life Science Services, LLC operates a robust distribution network with multiple facilities across the United States. While specific warehouse locations are not publicly disclosed, the company's extensive logistics capabilities are evident through its numerous subsidiaries and tier 1 supply chain connections. This infrastructure enables Eversana to efficiently manage the distribution of pharmaceutical products nationwide, ensuring timely and reliable delivery to clients. (data.ark.ai)

The company's strategic expansion includes the opening of a new office in Berlin, Germany, in October 2024, reflecting its commitment to enhancing global commercialization operations. This international presence indicates Eversana's capability to support pharmaceutical distribution beyond the United States, leveraging its logistics expertise to serve a global market.

3Industry Role

Eversana Life Science Services, LLC plays a pivotal role in the United States pharmaceutical supply chain as a comprehensive service provider. The company offers integrated solutions that encompass market access, product launch support, patient services, and distribution, effectively functioning as a primary wholesaler and logistics intermediary. By managing the entire commercialization process, Eversana ensures that pharmaceutical products reach the market efficiently and are accessible to patients, prescribers, and payers.

The company's extensive network of subsidiaries and supply chain connections further solidifies its position in the industry. This infrastructure enables Eversana to navigate complex regulatory environments and address the diverse needs of its clients, from emerging biotech firms to established pharmaceutical companies. (data.ark.ai)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Eversana Life Science Services, Llc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Eversana Life Science Services, LLC demonstrates a strategic sourcing approach with a notable concentration in its supplier base. The company imports finished pharmaceutical formulations from two primary Indian suppliers: RUBICON RESEARCH PRIVATE LIMITED, accounting for 75.9% of shipments, and RUBICON RESEARCH LIMITED, comprising 24.1%. This concentration suggests a strong, established relationship with these suppliers, potentially leading to favorable terms and streamlined logistics.

However, such dependency on a limited number of suppliers may pose risks, including supply chain disruptions due to geopolitical events, regulatory changes, or operational challenges within the supplier organizations. To mitigate these risks, Eversana may consider diversifying its supplier base and establishing contingency plans to ensure a resilient supply chain.

2Supply Chain Resilience

Eversana Life Science Services, LLC's supply chain resilience is supported by its diversified portfolio of 349 unique pharmaceutical formulations imported from India. This diversity indicates a broad sourcing strategy, reducing reliance on any single product line and enhancing the company's ability to adapt to market changes.

The company's established relationships with key Indian suppliers, such as RUBICON RESEARCH PRIVATE LIMITED and RUBICON RESEARCH LIMITED, suggest a level of stability in its supply chain. However, to further strengthen resilience, Eversana could explore additional backup suppliers and continuously monitor geopolitical and regulatory developments that may impact its supply chain operations.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and marketing of pharmaceutical products. The FDA enforces regulations that ensure the safety, efficacy, and quality of drugs entering the U.S. market. Key legislation governing pharmaceutical imports includes the Federal Food, Drug, and Cosmetic Act, which outlines the standards for drug approval and importation.

For Indian generics to enter the U.S. market, they must undergo the FDA's Abbreviated New Drug Application (ANDA) process. This pathway allows for the approval of generic drugs based on their bioequivalence to an already approved brand-name product, facilitating market entry while maintaining rigorous safety and efficacy standards.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products in the United States are stringent. Companies must obtain FDA registration and comply with Good Manufacturing Practice (GMP) standards to ensure product quality. The FDA recognizes GMP certifications from reputable international bodies, including the European Union's EU GMP, the World Health Organization's WHO GMP, and the Pharmaceutical Inspection Co-operation Scheme's PIC/S. These certifications are essential for foreign manufacturers seeking to export pharmaceutical products to the U.S.

Eversana Life Science Services, Llc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Eversana Life Science Services, LLC's focus on importing pharmaceutical products in the cardiovascular, antibiotics, and analgesics & antipyretics categories aligns with significant market demand in the United States. Cardiovascular diseases remain a leading cause of morbidity and mortality, driving the need for effective treatments. Antibiotics are essential for combating bacterial infections, while analgesics & antipyretics are widely used for pain management and fever reduction.

By concentrating on these therapeutic areas, Eversana addresses critical healthcare needs, positioning itself as a key player in providing essential medications to the U.S. market. This strategic focus enables the company to leverage its supply chain capabilities and supplier relationships to meet the demands of healthcare providers and patients.

2Sourcing Profile

Eversana Life Science Services, LLC's sourcing strategy emphasizes the importation of finished pharmaceutical formulations from India, particularly in the cardiovascular, antibiotics, and analgesics & antipyretics categories. This approach allows the company to offer a diverse range of products while maintaining a focus on high-demand therapeutic areas.

India's robust pharmaceutical manufacturing sector, characterized by its adherence to international quality standards and cost-effective production, makes it an attractive sourcing destination for Eversana. By importing finished formulations, Eversana can streamline its supply chain and ensure the timely availability of essential medications in the U.S. market.

Frequently Asked Questions — Eversana Life Science Services, Llc

What products does Eversana Life Science Services, Llc import from India?

Eversana Life Science Services, Llc imports 18 pharmaceutical products across 10 categories. Top imports: Metoprolol ($6.0M), Clindamycin ($4.2M), Amoxicillin ($3.8M), Glimepiride ($2.2M), Heparin ($1.9M).

Who supplies pharmaceuticals to Eversana Life Science Services, Llc from India?

Eversana Life Science Services, Llc sources from 2 verified Indian suppliers. The primary supplier is Rubicon Research Private Limited (75.9% of imports, $13.6M).

What is Eversana Life Science Services, Llc's total pharmaceutical import value?

Eversana Life Science Services, Llc's total pharmaceutical import value from India is $28.0M, based on 723 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Eversana Life Science Services, Llc focus on?

Eversana Life Science Services, Llc imports across 10 categories. The largest: Cardiovascular (38.3%), Antibiotics (28.4%), Analgesics & Antipyretics (9.4%).

Get Full Eversana Life Science Services, Llc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 3 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

Eversana Life Science Services, Llc

Eversana Life Science Services, Llc — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Eversana Life Science Services, Llc?

What Formulations Does Eversana Life Science Services, Llc Import?

What Products Does Eversana Life Science Services, Llc Import?

Top Products by Import Value

Eversana Life Science Services, Llc Therapeutic Categories — 10 Specializations